Cleveland Clinic's 20th Annual ASH Review

http://www.clevelandclinicmeded.com/live/courses/ashreview/

 

Cleveland Clinic's 20th Annual ASH Review
A

2019 ASH Review on Combinations or Sequences of Targeted Agents in CLL: Ibrutinib + Venetoclax for the 1st-Line Treatment - Should MRD Status at EOT Be Driving Treatment Decisions?

By Cleveland Clinic's 20th Annual ASH Review FEATURING Anthony R. Mato
By Cleveland Clinic's 20th Annual ASH Review FEATURING Anthony R. Mato
78 views
April 14, 2020
Comments 0
Login to view comments. Click here to Login
Malignant Hematology
07:01

2019 ASH Review of MDS: Clonal Hematopoiesis Increases Risk for Hema…

Cleveland Clinic's 20th Annual ASH Review

H. Carraway

23 views
26:41

2019 ASH Review on MDS: Luspatercept Under FDA Review, Novel Oral HM…

Cleveland Clinic's 20th Annual ASH Review

H. Carraway

31 views
14:17

2019 ASH Review on Anemia in Myelofibrosis: Luspatercept Improvement…

Cleveland Clinic's 20th Annual ASH Review

S. Mukherjee

22 views
14:51

ASH 2019 Review on Treating Myelofibrosis in the Setting of Thromboc…

Cleveland Clinic's 20th Annual ASH Review

S. Mukherjee

27 views
06:37

2019 ASH Review on Limited Stage DLBCL: Can We Use PET Scan to Tailo…

Cleveland Clinic's 20th Annual ASH Review

B. Hill

537 views
08:38

2019 ASH Review on R/R DLBCL: For Frail Unfit Patients, Addition of …

Cleveland Clinic's 20th Annual ASH Review

B. Hill

124 views
08:35

2019 ASH Review on MCL: Can Anti-CD19 CAR-T Cell Therapy Be Used for…

Cleveland Clinic's 20th Annual ASH Review

B. Hill

164 views
06:19

2019 ASH Review of Frontline CLL: Is There a Role for FCR in 2020 an…

Cleveland Clinic's 20th Annual ASH Review

A. Mato

343 views
07:59

2019 ASH Review of Frontline CLL: Can We Improve CIT by Adding a Nov…

Cleveland Clinic's 20th Annual ASH Review

A. Mato

177 views
05:08

2019 ASH Review on Combinations or Sequences of Targeted Agents in C…

Cleveland Clinic's 20th Annual ASH Review

A. Mato

78 views
04:52

2019 ASH Review on Venetoclax in the R/R CLL: With Additional Follow…

Cleveland Clinic's 20th Annual ASH Review

A. Mato

27 views
08:21

2019 ASH Review on Overcoming BTKi Resistance in CLL: Era of Non-Cov…

Cleveland Clinic's 20th Annual ASH Review

A. Mato

35 views
11:26

2019 ASH Review: Should High-risk Smoldering Myeloma Be Treated? Evi…

Cleveland Clinic's 20th Annual ASH Review

F. Anwer

21 views
05:49

2019 ASH Review on Newly Diagnosed Multiple Myeloma: VRD-Dara vs. VR…

Cleveland Clinic's 20th Annual ASH Review

F. Anwer

82 views
06:21

2019 ASH Review on Relapsed/Refractory: CAR T Cells - A New Frontier…

Cleveland Clinic's 20th Annual ASH Review

F. Anwer

123 views